Lehigh Press Pharmaceutical Products Inc is categorized under Molding Compounds, Plastics in , and active since 2006.
Lehigh Press Pharmaceutical Products Inc was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Molding Compounds, Plastics business, which does work in the B2B market, and is classified as a Molding Compounds, Plastics, under code number 325211 by the NAICS.
If you are seeking more information, feel free to contact John D Depaul at the company’s single location by writing to Km 12 4 Rr 189, , 00777 or by phoning (303) 783-9696. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lehigh Press Pharmaceutical Products Inc |
| Contact Person: | John D Depaul |
| Address: | Km 12 4 Rr 189, , 00777 |
| Phone Number: | (303) 783-9696 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Molding Compounds, Plastics |
| SIC Code: | 2821 |
| NAICS Code: | 325211 |
| Share This Business: |
Lehigh Press Pharmaceutical Products Inc was started in 2006 to provide professional Molding Compounds, Plastics under the SIC code 2821 and NAICS code 325211. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John D Depaul for inquiries that concern Lehigh Press Pharmaceutical Products Inc by calling the company number (303) 783-9696, as your correspondence is most welcome. Additionally, the physical location of the single location of Lehigh Press Pharmaceutical Products Inc can be found at the coordinates as well as the street address Km 12 4 Rr 189 in , 00777.
For its online presence, you may visit Lehigh Press Pharmaceutical Products Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.